DuPont stock price target raised to $93 from $92 at KeyBanc

Investing.com - KeyBanc raised its price target on DuPont (NYSE:DD) to $93.00 from $92.00 on Monday, while maintaining an Overweight rating on the chemical company’s stock. According to InvestingPro data, DuPont’s current market performance shows promising indicators, with analysts predicting continued profitability for the year ahead.

The price target adjustment follows KeyBanc’s attendance at investor days for both DuPont and its upcoming spinoff company Qnity Electronics (NYSE:Q). KeyBanc expressed increased confidence in its sum-of-the-parts (SOTP) valuation framework, which suggests 20-25% upside potential for DuPont following the Qnity spin-off. For deeper insights into both companies’ valuations and financial health metrics, InvestingPro subscribers can access comprehensive analysis and over 10 additional ProTips.

KeyBanc views management’s organic growth targets as "modestly conservative," with DuPont targeting 3-4% growth and Qnity Electronics aiming for 6-7%. The firm believes there is greater than 50% probability that both companies will exceed these targets over the next one to two years.

The investment bank also noted potential for additional upside beyond its current price target if both companies successfully execute on their stated organic growth objectives.

The firm’s analysis follows its participation in the investor day presentations, which provided detailed information about the strategic direction for both DuPont and the soon-to-be-independent Qnity Electronics.

In other recent news, Qualitas Controladora, SAB De CV reported its second-quarter 2025 earnings, revealing a notable shortfall in both earnings per share (EPS) and revenue compared to analyst forecasts. The company announced an EPS of $3.54, which was significantly below the expected $4.78, resulting in a surprise of -25.94%. Revenue also fell short of expectations, coming in at $17.41 billion compared to the forecasted $17.72 billion, marking a surprise of -1.75%. These results were followed by a decline in the company’s stock price.

Analysts had anticipated better performance, and the results have led to increased scrutiny of the company’s financial health. The earnings miss highlights challenges that Qualitas may face in meeting market expectations. Investors will likely be interested in how the company plans to address these issues moving forward.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.